Kairos Pharma, Ltd. (KAPA)
NYSEAMERICAN: KAPA · Real-Time Price · USD
0.6055
+0.0532 (9.63%)
Feb 27, 2026, 4:00 PM EST - Market closed
Kairos Pharma Market Cap
Kairos Pharma has a market cap or net worth of $12.61 million as of February 27, 2026. Its market cap has decreased by -31.84% in one year.
Market Cap
12.61M
Enterprise Value
7.03M
1-Year Change
-31.84%
Ranking
Category
Stock Price
$0.61
Market Cap Chart
Since the IPO on September 16, 2024, Kairos Pharma's market cap has decreased from $33.39M to $12.61M, a decrease of -62.24%. That is a compound annual growth rate of -49.00%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 26, 2026 | 11.50M | -22.21% |
| Dec 31, 2025 | 14.78M | -24.29% |
| Dec 31, 2024 | 19.53M | -41.52% |
| Sep 16, 2024 | 33.39M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Quantum BioPharma | 13.76M |
| Iterum Therapeutics | 13.74M |
| BioCardia | 13.27M |
| NewcelX | 12.95M |
| Traws Pharma | 12.63M |
| BioLineRx | 12.52M |
| CytoMed Therapeutics | 12.34M |
| Cardio Diagnostics Holdings | 12.25M |